Marinomed Biotech AG | WebDisclosure

PRESS RELEASE

published on 09/15/2024 at 17:49, 2 months 8 days ago

EQS-Adhoc: Marinomed Biotech AG sets price range for potential 10% capital increase and potential second capital increase, in each case excluding statutory subscription rights
Marinomed Biotech AG sets price range for potential 10% capital increase and second capital increase, excluding statutory subscription rights

Capital Increase Marinomed Biotech AG Price Range Authorized Capital 2024 Restructuring Proceedings
BRIEF

published on 09/11/2024 at 07:50, 2 months 12 days ago

Marinomed Biotech AG : les premiers produits à base de carraghénane reçoivent la nouvelle certification du Règlement sur les dispositifs médicaux (MDR)

Dispositifs Médicaux Conformité Réglementaire Certification MDR Marinomé Carraghénose
BRIEF

published on 09/11/2024 at 07:50, 2 months 12 days ago

Marinomed Biotech AG: First Carragelose Products Receive New Medical Device Regulation (MDR) Certification

Regulatory Compliance Medical Devices Carragelose MDR Certification Marinomed
PRESS RELEASE

published on 09/11/2024 at 07:45, 2 months 12 days ago

Marinomed Biotech AG: First Carragelose products receive new Medical Device Regulation (MDR) certification
Marinomed Biotech AG's first Carragelose products receive new Medical Device Regulation (MDR) certification, enhancing safety and value for the portfolio

Regulatory Compliance Medical Devices Marinomed Biotech AG MDR Certification Carragelose Products
BRIEF

published on 09/02/2024 at 17:51, 2 months 21 days ago

Marinomed Biotech AG Evaluates 10% Capital Increase

Investors Shares Capital Increase Restructuring Marinomed
BRIEF

published on 09/02/2024 at 17:51, 2 months 21 days ago

Marinomed Biotech AG évalue une augmentation de capital de 10 %

Actions Augmentation De Capital Investisseurs Restructuration Marinomé
PRESS RELEASE

published on 09/02/2024 at 17:46, 2 months 21 days ago

EQS-Adhoc: Marinomed Biotech AG evaluates possible 10% capital increase with exclusion of statutory subscription rights
Marinomed Biotech AG evaluates a possible 10% capital increase excluding statutory subscription rights to finance ongoing costs in restructuring proceedings. Management Board to discuss with selected investors for potential transaction

Capital Increase Management Board Marinomed Biotech AG Restructuring Proceedings Statutory Subscription Rights
BRIEF

published on 08/20/2024 at 18:05, 3 months 3 days ago

Marinomed Biotech AG Reports Preliminary Financial Figures for H1 2024

Financial Results Product Development Restructuring Proceedings Q2 Revenue Growth New Partnerships
BRIEF

published on 08/20/2024 at 18:05, 3 months 3 days ago

Marinomed Biotech AG publie ses résultats financiers préliminaires pour le premier semestre 2024

Résultats Financiers Développement De Produits Croissance Du Chiffre D'affaires Au Deuxième Trimestre Procédure De Restructuration Nouveaux Partenariats
PRESS RELEASE

published on 08/20/2024 at 18:00, 3 months 3 days ago

Marinomed Biotech AG reports preliminary financial figures for the first half of 2024
Marinomed Biotech AG reports preliminary financial figures for the first half of 2024, including a decline in revenues compared to 2023. The company aims to stabilize through restructuring and new partnerships

Restructuring Preliminary Results Financial Figures Partnerships Marinomed Biotech AG

Published on 11/22/2024 at 23:55, 1 day 1 hour ago

Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 1 day 1 hour ago

Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 1 day 2 hours ago

Kidoz Inc. Announces Results of 2024 AGM
Published on 11/22/2024 at 23:05, 1 day 2 hours ago

Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 1 day 2 hours ago

Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.

View all ACCESSWIRE

Published on 11/22/2024 at 18:14, 1 day 6 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 18:00, 1 day 7 hours ago

Holding(s) in Company
Published on 11/22/2024 at 17:53, 1 day 7 hours ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 1 day 8 hours ago

EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 1 day 9 hours ago

Proposed cancellation of admission to trading

View all EQS

Published on 11/22/2024 at 17:45, 1 day 7 hours ago

IMMERSION : RFA 2023/2024
Published on 11/22/2024 at 16:15, 1 day 8 hours ago

NRJ GROUP - Le Conseil d'Etat rejette le recours de NRJ 12 et NRJ GROUP
Published on 11/22/2024 at 14:35, 1 day 10 hours ago

Communiqué de presse Thales
Published on 11/22/2024 at 14:35, 1 day 10 hours ago

Thales Press release
Published on 11/21/2024 at 06:58, 2 days 18 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio

View all LES ECHOS COMFI WIRE

News